Skip to content Skip to navigation

Quality of reporting in randomized trials

| Reprints
April 1, 2010
by Robert T. Sataloff, MD, DMA, FACS, Editor-in-Chief

A great deal of emphasis has been placed recently on the importance of high-quality evidence in medical literature. Placebo-controlled, randomized, prospective studies are valued especially highly.

ENT Journal provides full text articles to our registered members.
Please log in or sign up for a FREE membership to view the full content:

You may also like to: